Macquarie Group’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$782K Hold
46,629
﹤0.01% 1401
2025
Q1
$717K Sell
46,629
-3,450
-7% -$53K ﹤0.01% 1435
2024
Q4
$1.1M Buy
50,079
+4,415
+10% +$97.3K ﹤0.01% 1336
2024
Q3
$823K Buy
45,664
+2,330
+5% +$42K ﹤0.01% 1411
2024
Q2
$704K Sell
43,334
-741
-2% -$12K ﹤0.01% 1426
2024
Q1
$622K Buy
44,075
+9,942
+29% +$140K ﹤0.01% 1423
2023
Q4
$357K Buy
34,133
+786
+2% +$8.21K ﹤0.01% 1500
2023
Q3
$340K Sell
33,347
-4,596
-12% -$46.9K ﹤0.01% 1476
2023
Q2
$286K Sell
37,943
-5,197
-12% -$39.1K ﹤0.01% 1514
2023
Q1
$382K Hold
43,140
﹤0.01% 1489
2022
Q4
$393K Buy
43,140
+6,483
+18% +$59.1K ﹤0.01% 1541
2022
Q3
$296K Sell
36,657
-210
-0.6% -$1.7K ﹤0.01% 1575
2022
Q2
$278K Sell
36,867
-8,243
-18% -$62.2K ﹤0.01% 1663
2022
Q1
$424 Hold
45,110
﹤0.01% 1681
2021
Q4
$361K Sell
45,110
-55,760
-55% -$446K ﹤0.01% 1683
2021
Q3
$982K Buy
100,870
+8,879
+10% +$86.4K ﹤0.01% 1588
2021
Q2
$910K Sell
91,991
-15,463
-14% -$153K ﹤0.01% 1613
2021
Q1
$1.24M Hold
107,454
﹤0.01% 1339
2020
Q4
$1.04M Sell
107,454
-501,700
-82% -$4.84M ﹤0.01% 1305
2020
Q3
$5.49M Buy
609,154
+49,726
+9% +$448K 0.01% 807
2020
Q2
$6.9M Sell
559,428
-1,463,872
-72% -$18.1M 0.01% 717
2020
Q1
$18.2M Hold
2,023,300
0.04% 437
2019
Q4
$19.8M Buy
2,023,300
+16,400
+0.8% +$161K 0.03% 519
2019
Q3
$13.8M Hold
2,006,900
0.02% 534
2019
Q2
$18.5M Buy
2,006,900
+530,000
+36% +$4.89M 0.03% 477
2019
Q1
$23.2M Buy
1,476,900
+1,445,400
+4,589% +$22.7M 0.04% 423
2018
Q4
$485K Sell
31,500
-700
-2% -$10.8K ﹤0.01% 1293
2018
Q3
$693K Sell
32,200
-102,700
-76% -$2.21M ﹤0.01% 1265
2018
Q2
$3.28M Sell
134,900
-23,000
-15% -$559K 0.01% 865
2018
Q1
$2.7M Sell
157,900
-4,800
-3% -$82K ﹤0.01% 908
2017
Q4
$3.68M Sell
162,700
-4,245,631
-96% -$95.9M 0.01% 858
2017
Q3
$77.6M Buy
4,408,331
+3,429,448
+350% +$60.4M 0.14% 129
2017
Q2
$32.5M Buy
978,883
+43,757
+5% +$1.45M 0.06% 313
2017
Q1
$30M Buy
935,126
+15,153
+2% +$486K 0.05% 337
2016
Q4
$33.3M Buy
919,973
+29,770
+3% +$1.08M 0.06% 281
2016
Q3
$41M Sell
890,203
-1,069,889
-55% -$49.2M 0.08% 221
2016
Q2
$98.5M Buy
1,960,092
+688,074
+54% +$34.6M 0.1% 169
2016
Q1
$68.1M Sell
1,272,018
-739,908
-37% -$39.6M 0.14% 120
2015
Q4
$132M Sell
2,011,926
-1,476,924
-42% -$96.9M 0.27% 72
2015
Q3
$197M Sell
3,488,850
-1,261,907
-27% -$71.2M 0.42% 58
2015
Q2
$281M Sell
4,750,757
-762,169
-14% -$45M 0.56% 48
2015
Q1
$343M Sell
5,512,926
-1,922,569
-26% -$120M 0.67% 40
2014
Q4
$428M Sell
7,435,495
-789,346
-10% -$45.4M 0.88% 36
2014
Q3
$442M Buy
8,224,841
+72,645
+0.9% +$3.9M 0.95% 36
2014
Q2
$427M Sell
8,152,196
-612,105
-7% -$32.1M 0.95% 31
2014
Q1
$463M Sell
8,764,301
-1,488,238
-15% -$78.6M 0.8% 27
2013
Q4
$411M Buy
10,252,539
+1,118,270
+12% +$44.8M 0.74% 42
2013
Q3
$345M Buy
9,134,269
+1,449,823
+19% +$54.8M 0.67% 54
2013
Q2
$301M Buy
+7,684,446
New +$301M 0.66% 60